| Literature DB >> 34307295 |
Nicolò Bisi1, Lucia Feni2, Kaliroi Peqini2, Helena Pérez-Peña3, Sandrine Ongeri1, Stefano Pieraccini3, Sara Pellegrino2.
Abstract
Alpha-synuclein (αSyn) is a highly expressed and conserved protein, typically found in the presynaptic terminals of neurons. The misfolding and aggregation of αSyn into amyloid fibrils is a pathogenic hallmark of several neurodegenerative diseases called synucleinopathies, such as Parkinson's disease. Since αSyn is an Intrinsically Disordered Protein, the characterization of its structure remains very challenging. Moreover, the mechanisms by which the structural conversion of monomeric αSyn into oligomers and finally into fibrils takes place is still far to be completely understood. Over the years, various studies have provided insights into the possible pathways that αSyn could follow to misfold and acquire oligomeric and fibrillar forms. In addition, it has been observed that αSyn structure can be influenced by different parameters, such as mutations in its sequence, the biological environment (e.g., lipids, endogenous small molecules and proteins), the interaction with exogenous compounds (e.g., drugs, diet components, heavy metals). Herein, we review the structural features of αSyn (wild-type and disease-mutated) that have been elucidated up to present by both experimental and computational techniques in different environmental and biological conditions. We believe that this gathering of current knowledge will further facilitate studies on αSyn, helping the planning of future experiments on the interactions of this protein with targeting molecules especially taking into consideration the environmental conditions.Entities:
Keywords: in silico studies; intrinsically disordered protein; protein interaction; secondary and tertiary structure; synucleinopathy
Year: 2021 PMID: 34307295 PMCID: PMC8292672 DOI: 10.3389/fchem.2021.666585
Source DB: PubMed Journal: Front Chem ISSN: 2296-2646 Impact factor: 5.221
FIGURE 1The three αSyn regions are represented in different colors. Their properties, along with the main PD mutations and interacting sites are indicated.
Reported experimental and computational data on monomeric wt αSyn.
| Structural features | Technique | References | ||
|---|---|---|---|---|
| Global | Local | Experimental | Computational | |
| Compact, globular structure Electrostatic interactions (120–140 and 30–100 residues) | – | Technique: PRE1 | Technique: MD2 |
|
| Spin label MTSL | ||||
| Cysteine mutations at Q24, S42, Q62, S87 and N103 | ||||
| Brief long-range intramolecular electrostatic interactions | – | Technique: NMR3 | – |
|
| 100uM WT αSyn in buffer (25mM Tris.Cl pH = 7.4/0.1M NaCl) | ||||
| Extended tendency | N-terminal: Helical elements | Technique: NMR3 | Technique: restrained MD2 |
|
| Brief long-range intramolecular electrostatic interactions | Solvent: implicit | |||
| Compact structure at both neutral and low pH | – | Technique: PRE1 | – |
|
| C- to N-terminal interchain interactions | Various pH, concentrations, solvents | |||
| Compact structure (low pH) | – | Technique: Single-Molecule FRET4 | Technique: constrained excluded volume MC5 |
|
| 50 pM solution of double-labeled WT αSyn | Technique: All-atom MD2 | |||
| Solvent: explicit | ||||
| High-energy phase: Extended random coil Low-energy phase: Extended all-β | High-energy phase: | – | Technique: MC5 |
|
| N-terminal: Helical elements | Solvent: Implicit | |||
| Low-energy phase: | ||||
| N-terminal + NAC + C-terminal (residues 30–100): β-strands | ||||
| C-terminal: β-structures + random coil | ||||
| – | N-terminal + NAC + C-terminal (residues 1–100): Helical elements | – | Technique: REMD6 |
|
| Solvents: implicit | ||||
| Technique: MD2 | ||||
| Solvents: explicit | ||||
| Compact structure | N-terminal: Helical elements + β-hairpin spanning residues 38–53 | – | Technique: coarse-grained MD2 |
|
| Electrostatic interactions (118–130 and 38–53 residues) | β-strands: β1 (38–44) and β2 (47–53) | Solvent: explicit | ||
| α+β | NAC: Helical elements | |||
| C-terminal: Helical elements + β-structures | ||||
| Compact, globular structure | N-terminal: Helical elements | Technique: HS-AFM7 | Technique: REX8/DMD9 |
|
| Tail-like protrusions | NAC: Helical elements | 50nM WT αSyn in PBS | Solvent: Lazaridis-Karplus implicit | |
| All-α | C-terminal: Helical elements | |||
| Compact, globular structure | N-terminal: Helical elements spanning residues 25–55 | Techniques: | Technique: REX8/DMD9 |
|
| Brief long-range intramolecular | NAC: β-structures | LD-CL10, CD11,HDX12, | Solvent: Lazaridis-Karplus implicit | |
| electrostatic interactions α+β | C-terminal: β-structures + random coil | LC-MS13/MS Analysis | ||
| Compact, globular structure | N-terminal: Helical elements | – | Technique: MD2 |
|
| Tail-like protrusions | NAC: Helical elements | Solvents: explicit | ||
| All-α | C-terminal: Helical elements + random coil | |||
| – | N-terminal: Helical elements spanning residues 10–30 and a weak helix centered around residue 50 | Technique: NMR3 | – |
|
| NAC: tendency to form β-structures helix centered around residue 90 | ||||
Paramagnetic Relaxation Enhancement.
Molecular Dynamics simulations.
Nuclear magnetic resonance.
Fluorescence resonance energy transfer.
Monte Carlo simulations.
Replica Exchange Molecular Dynamics simulations.
High-Speed Atomic Force Microscopy.
All-atom Replica Exchange.
Discrete Molecular Dynamics.
Long-distance crosslinking.
Circular dichroism.
Hydrogen-deuterium exchange.
Liquid chromatography–mass spectrometry.
FIGURE 2DMD centroids of the most frequent monomeric WT αSyn lowest energy clusters. Clusters representing a (A) ∼76%, (B) 15%, and (C) ∼4% of the overall population. αSyn N-terminal region (residues 1–60) is colored in orange, the NAC-region (residues 61–95) is colored in green and the C-terminal region (residues 96–140) is colored in yellow (Zhang et al., 2018).
FIGURE 3CL-DMD WT monomeric αSyn models. Centroids from the most relevant conformational clusters containing (A) 37%, (B) 28%, (C) 20%, and (D) 8% of the overall population. αSyn N-terminal region (residues 1–60) is colored in orange, the NAC-region (residues 61–95) is colored in green and the C-terminal region (residues 96–140) is colored in yellow (Brodie et al., 2019).
FIGURE 4MD WT monomeric aSyn models. Centroid from the most relevant conformational clusters. This figure has been reproduced upon copy right permissions (Yu et al., 2015).
FIGURE 5Structural changes in αSyn and the hydrophobic regions. Structure of (A) wild type (1XQ8) in SDS solvent, (B) wild type (1XQ8) simulated in explicit water conditions, (C) A30P mutant in water solvent, (D) E46K mutant in water solvent, (E) A53T mutant in water solvent. The blue region depicts the 36–41 and 68–78 hydrophobic regions in αSyn showing aggregation propensity (Kumar et al., 2009).
FIGURE 6Tertiary structure of the initial NMR conformations of the mutants containing a significant percentage of α-helices changes during MD. Figure modified from Tsigelny et al. (2015).
FIGURE 7Different biological factors/modulators influencing αSyn structure. The figure is composed of two sections referring to proteins (left panel) and lipid membranes (right panel), which have an important role in the conformational change of αSyn from being an intrinsically disordered protein (IDP) to induce a more stable structure. Right panel: special emphasis is placed on the type of study performed, classified in computational, in vitro and in vivo experiments, and on the particular interaction of the proteins with the distinct αSyn configurations (fibrils, oligomers, monomers). Hsp70 and Hsp73 heat shock protein 70 and 73; SCGN: secretagogin. Left panel: The equilibrium between horseshoe and linear conformation is highlighted and the partition of αSyn in three regions is depicted to show the different behavior throughout the sequence when in contact with lipid membranes. The important interaction with mitochondrial membranes and lipid rafts is also mentioned here. GM1: monosialotetrahexosylganglioside.
Reported proteins interactions with monomeric and aggregated states of αSyn.
| Compound | α-Syn interaction region | α-Syn state conversion upon interaction | Common features (class) | References |
|---|---|---|---|---|
| Tubulin | Not specified | Folding into helical structure | Microtubule protein |
|
| Hsp70 | NAC and 95VKKDQ99 (at the border between NAC and C-terminal) | Fibrils → soluble conformers | Chaperone |
|
| Monomers → stabilized monomers |
| |||
|
| ||||
|
| ||||
| Hsp73 | Not specified | Monomers → stabilized monomers | Chaperone |
|
| DNAJB6 | Not specified | Non specified | Co-chaperone |
|
|
| ||||
| DNAJB1 | Non specified | Fibrils → shorter fibrils → monomers | Co-chaperone |
|
| SCGN | Non specified | Monomers and early-stage oligomers → soluble conformers | Ca2+-binding protein |
|
| AS69 | Y39, H50 | Monomers → stabilized monomers | Engineered protein |
|
|
|
FIGURE 8Ribbon drawing illustrating the structure of Hsp70 with its different domains (PDB file 2KHO).
FIGURE 9(A) Ribbon drawing of the AS69 structure interacting with the αSyn β-hairpin (residues 36–55). In light orange and green, the two subunits of AS69 are shown. Each subunit spans residues 13–58 of AS69. (B) Ribbon drawing of the αSyn β-hairpin (orange, β1 and β2 strands). H-bonds are depicted by dashed lines. The main interacting residues are shown as sticks (Mirecka et al., 2014).
FIGURE 10Endogenous small molecules affecting αSyn conformation and aggregation.
Reported endogenous and exogenous small molecules interactions with monomeric and aggregated states of αSyn.
| Compound | α-Syn interaction region | α-Syn state conversion upon interaction | Common features (class) | References |
|---|---|---|---|---|
| Dopamine | 125YEMPS129 (C-terminal) and E83 (NAC) | Oligomers → complex/trimers lacking β-sheets | Neurotransmitter |
|
|
| ||||
|
| ||||
| Arginine | Aromatic residues | Monomers → unstructured conformer | Neurotransmitter | S. |
| Glutamate | Not specified | Monomers → β-sheet rich oligomers | Neurotransmitter | S. |
| EGCG | Residues 23–55 (N-terminal) | Monomers and fibrils → non-toxic entities | Polyphenol |
|
|
| ||||
|
| ||||
|
| ||||
| Baicalein | Lysine and tyrosine side chains (mainly N-terminal) | Monomers and fibrils → non-toxic oligomers | Polyphenol |
|
|
| ||||
|
| ||||
|
| ||||
| NDGA | V3, F4, Met5 and H50 (N-terminal) | Monomers → stabilized monomers | Polyphenol |
|
| Fibrils → low β-sheet complexes |
| |||
|
| ||||
| Squalamine | Residues 113–139 (C-terminal) | Not specified | Triterpenoid |
|
| Nicotine | Not specified | Monomers → soluble oligomers | Alkaloid |
|
| Caffeine | Not specified | Oligomers → mature aggregates | Alkaloid |
|
|
| ||||
| Mannitol | Not specified | Oligomers → non-toxic entities | Sugar alcohol |
|
| Scyllo-inositol | NAC | Monomers → stabilized monomers | Sugar alcohol |
|
| TANI and TAN IIA | Not specified | Monomers/oligomers/fibrils → non-toxic entities | Phenanthrenequinone |
|
|
| ||||
| Cuminaldehyde | Lysine side chains (N-terminal) | Monomers → α-helix-like complexes | Aldehyde |
|
| PcTs | F4 and Y39 (N-terminal), residues 93–95 | Monomers → α-helix stabilized monomers | Phthalocyanines |
|
| (C-terminal) |
| |||
| C41 | N-terminal | Monomers/oligomers/fibrils → non-toxic entities | 4-Hydroxynaphthalen-1-yl)sulphonamide derivatives |
|
| NQTrp | Not specified | Monomers → non-toxic entities | Naphtoquinone-Tryptophan derivative |
|
| M2N and M3N | Not specified | Fibrils → amorphic conformers | Mannitol derivatives |
|
FIGURE 11Binding sites recognized in the interaction between αSyn monomer and different exogenous factors (natural and synthetic small molecules, metals). The coordination between the protein and these factors leads to a balance that is always shifting between conformational stabilization and induction of aggregation. In the box regarding “metals,” the specific coordination modes of Cu(II), all divalent cations, lanthanides with the specific amino acid residues are detailed. EGCG: Epigallocatechin gallate; PcTs: phthalocyanine tetra sulfonate.
FIGURE 12Natural small molecules influencing αSyn conformation properties.
FIGURE 13Synthetic small molecules effective on αSyn aggregation.